Arabesque Asset Management’s AbbVie ABBV Stock Holding History

Arabesque Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-29,045	Closed	-$4.69M	–	2
2022 Q4	$4.69M	Buy	29,045 +12,883	+80%	+$1.98M	1.59%	6
2022 Q3	$2.17M	Buy	16,162 +2,200	+16%	+$316K	1.06%	35
2022 Q2	$2.14M	Buy	13,962 +9,050	+184%	+$1.38M	1.13%	22
2022 Q1	$796K	Sell	4,912 -11,784	-71%	-$1.71M	0.28%	115
2021 Q4	$2.26M	Buy	+16,696	New	+$1.97M	0.65%	70
2021 Q2	–	Sell	-17,723	Closed	-$1.92M	–	131
2021 Q1	$1.92M	Buy	+17,723	New	+$1.9M	0.85%	38

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Arabesque Asset Management's ABBV Position: Q1 2023 in Review

Arabesque Asset Management sold out of AbbVie (ABBV) in Q1 2023, closing a stake of 29,045 shares — an estimated $4.69M sold.

Arabesque Asset Management first reported a position in ABBV in Q1 2021 and held it in 6 quarters. The position peaked at $4.69M in Q4 2022. 3,141 funds tracked by Wall St. Rank hold ABBV as of Q1 2023.

Arabesque Asset Management reported no remaining AbbVie position as of Q1 2023 after selling out during the quarter.
Arabesque Asset Management sold 29,045 AbbVie shares in Q1 2023, an estimated $4.69M.
Arabesque Asset Management first reported a position in AbbVie in Q1 2021 and held it in 6 quarters.
Arabesque Asset Management's AbbVie position peaked at $4.69M in Q4 2022.
3,141 funds tracked by Wall St. Rank held AbbVie as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.